Prices are updated after-hours

Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

approved   symbols : Bhvn    save search

BIOHAVEN ANNOUNCES NURTEC® ODT RECEIVES FIRST GLOBAL APPROVAL OUTSIDE THE U.S. FOR PREVENTION OF MIGRAINE
Published: 2021-12-13 (Crawled : 13:00) - biospace.com/
BHVN | News 0 d | $40.735 6.27% 820K twitter stocktwits trandingview |
Health Technology
| | O: -2.49% H: 0.0% C: 0.0%

nurtec approval migraine
NURTEC® ODT Approved In Kuwait For Acute Treatment Of Migraine
Published: 2021-11-17 (Crawled : 14:30) - biospace.com/
BHVN | News 0 d | $40.735 6.27% 820K twitter stocktwits trandingview |
Health Technology
| | O: -0.75% H: 0.0% C: 0.0%

treatment migraine approval
Biohaven Showcases CGRP-Antagonist Franchise Data including Nurtec® ODT (rimegepant), Now Approved to Treat and Prevent Migraine Attacks, and Zavegepant with 19 Presentations at the 2021 Virtual Annual Scientific Meeting of the American Headache Society
Published: 2021-06-03 (Crawled : 12:00) - prnewswire.com
BHVN | News 0 d | $40.735 6.27% 820K twitter stocktwits trandingview |
Health Technology
| | O: -0.22% H: 1.91% C: -0.21%

presentation migraine
FDA Approves Biohaven's NURTEC® ODT (rimegepant) for Prevention: Now the First and Only Migraine Medication for both Acute and Preventive Treatment
Published: 2021-05-27 (Crawled : 22:00) - biospace.com/
BHVN | News 0 d | $40.735 6.27% 820K twitter stocktwits trandingview |
Health Technology
| | O: -0.01% H: 2.56% C: 2.0%

treatment fda migraine fda approval
Biohaven's NURTEC® ODT Approved In United Arab Emirates For Acute Treatment Of Migraine
Published: 2021-03-11 (Crawled : 14:00) - biospace.com/
BHVN | News 0 d | $40.735 6.27% 820K twitter stocktwits trandingview |
Health Technology
| | O: 2.38% H: 4.18% C: 2.68%

treatment migraine approval
Biohaven's NURTEC® ODT Approved In Israel For Acute Treatment Of Migraine
Published: 2021-03-10 (Crawled : 22:03) - biospace.com/
BHVN | News 0 d | $40.735 6.27% 820K twitter stocktwits trandingview |
Health Technology
| | O: 1.54% H: 0.95% C: -7.25%

israel treatment migraine approval
Gainers vs Losers
89% 11%

Top 10 Gainers
MTTR | News M | $4.65 167.24% 9.8M twitter stocktwits trandingview |

AGBA | $2.355 88.4% 34M twitter stocktwits trandingview |
Finance

EDBL | News | $6.94 84.57% 1.4M twitter stocktwits trandingview |

CZOO | $8.77 75.75% 11M twitter stocktwits trandingview |

VNRX | $0.84 40.0% 2.6M twitter stocktwits trandingview |
Health Technology

OPRT | News | $3.01 33.78% 6.8M twitter stocktwits trandingview |
Finance

MLEC | $1.81 29.29% 2M twitter stocktwits trandingview |
n/a

CMAX | $4.12 28.35% 65K twitter stocktwits trandingview |
Manufacturing

MTC | $2.0 28.21% 1.7M twitter stocktwits trandingview |
Technology Services

PEGY | $0.0586 27.95% 130M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.